1. Proatherogenic role for NK cells revealed. Linton MF, Major AS, Fazio S (2004) Arterioscler Thromb Vasc Biol 24(6): 992-4
    › Primary publication · 15178571 (PubMed)
  2. Cyclooxygenase-2 and inflammation in atherosclerosis. Linton MF, Fazio S (2004) Curr Opin Pharmacol 4(2): 116-23
    › Primary publication · 15063354 (PubMed)
  3. Combined adipocyte-macrophage fatty acid-binding protein deficiency improves metabolism, atherosclerosis, and survival in apolipoprotein E-deficient mice. Boord JB, Maeda K, Makowski L, Babaev VR, Fazio S, Linton MF, Hotamisligil GS (2004) Circulation 110(11): 1492-8
    › Primary publication · 15353487 (PubMed) · PMC4027050 (PubMed Central)
  4. Angiotensin II amplifies macrophage-driven atherosclerosis. Nobuhiko A, Suganuma E, Babaev VR, Fogo A, Swift LL, Linton MF, Fazio S, Ichikawa I, Kon V (2004) Arterioscler Thromb Vasc Biol 24(11): 2143-8
    › Primary publication · 15374850 (PubMed)
  5. The recycling of apolipoprotein E in primary cultures of mouse hepatocytes. Evidence for a physiologic connection to high density lipoprotein metabolism. Farkas MH, Swift LL, Hasty AH, Linton MF, Fazio S (2003) J Biol Chem 278(11): 9412-7
    › Primary publication · 12524433 (PubMed)
  6. Premature coronary-artery atherosclerosis in systemic lupus erythematosus. Asanuma Y, Oeser A, Shintani AK, Turner E, Olsen N, Fazio S, Linton MF, Raggi P, Stein CM (2003) N Engl J Med 349(25): 2407-15
    › Primary publication · 14681506 (PubMed)
  7. Macrophages, inflammation, and atherosclerosis. Linton MF, Fazio S (2003) Int J Obes Relat Metab Disord : S35-40
    › Primary publication · 14704742 (PubMed)
  8. Macrophage apolipoprotein A-I expression protects against atherosclerosis in ApoE-deficient mice and up-regulates ABC transporters. Su YR, Ishiguro H, Major AS, Dove DE, Zhang W, Hasty AH, Babaev VR, Linton MF, Fazio S (2003) Mol Ther 8(4): 576-83
    › Primary publication · 14529830 (PubMed)
  9. Inactivation of macrophage scavenger receptor class B type I promotes atherosclerotic lesion development in apolipoprotein E-deficient mice. Zhang W, Yancey PG, Su YR, Babaev VR, Zhang Y, Fazio S, Linton MF (2003) Circulation 108(18): 2258-63
    › Primary publication · 14581413 (PubMed)
  10. Hepatocyte-derived ApoE is more effective than non-hepatocyte-derived ApoE in remnant lipoprotein clearance. Raffaï RL, Hasty AH, Wang Y, Mettler SE, Sanan DA, Linton MF, Fazio S, Weisgraber KH (2003) J Biol Chem 278(13): 11670-5
    › Primary publication · 12551940 (PubMed)